FDA Investigator Brien C Fox
Brien C Fox has inspections in 1 countries as of 14 Sep 2023. Brien C Fox has collaborated with a combinined 1992 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amalia C Himaya,
Amalia Himaya,
Anita Narula, PhD,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Barry Cherney, PhD,
Bichsa T Nguyen,
Bichsa T Tran,
Binh T Nguyen,
Bo Chi, PhD,
Brian J Ryan,
Bryan A Galvez,
Carla J Lundi,
Carolina D Vasquez,
Carr Sharpe,
Caryn M Everly,
Caryn M Mcnab,
Chelsea N Sealey,
Cheron M Portee,
Christina V Santos,
Daniel W Cline,
Davinna Ligons, PhD,
Deborah A Greco,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Donna Mwilliams Hill,
Esther B Gamallo Herrera,
Frances Namuswe, PhD,
Gene D Arcy,
Haley H Seymour,
Haley Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Heidy C Perales,
Iris C Macinnes,
James M Timper Jr,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Joel Welch, PhD,
John R Myung,
Julie A Rorberg,
Julie A Stocklin,
Julie Rorberg,
Jun Park, PhD,
Ka L Wong,
Kathleen R Jones, PhD,
Kathy Chiu,
Kathy Kuo,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kenneth H Williams,
Kim Lthomas Cruse,
Kim Thomas Chase,
Laura Fontan, MS,
Leonard H Lavi,
Linda Thai,
Ling Yul Liu,
LT Richard A Lyght,
Marcia Britt Williams,
Marcus F Yambot,
Mary Ewilkerson Brinsko,
Maxyne T Lam,
Michael D Garcia,
Michelle A Marsh,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Peter S Diak,
Rebecca Rodriguez,
Richard C Chiang,
Richmond K Yip,
Robert D Tollefsen,
Robert Darius,
Roger F Zabinski,
Ronald L Koller,
Ronda Lebland,
Rumany C Penn, PharmD,
Saied A Asbagh,
Santiago Gallardo Johnson,
Sarah Arden,
Scott R Nichols, PhD,
Sean P Desbrow,
Selene T Torres,
Sidney B Priesmeyer,
Sonia R Peterson,
Stanley Au,
Stephanie A Slater, MS,
Steven Fong, MS, PhD,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Terri L Dodds,
Thao T Kwan,
Thao Tran,
Thao X Tran,
Thomas J Arista,
Timothy P Lafave,
Uttaniti Limchumroon (Tom),
Vickie L Anderson,
Virgilio F Pacio, CSO,
Yumi J Hiramine,
Yvonne C Wilkes,
Zachary A Bogorad
Brien C Fox's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2002 | FDA 483 | Polypeptide Laboratories Inc - Form 483, 2002-11-27 |
| February, 2003 | EIR | Amgen, Inc - EIR, 2003-02-26 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more